Search companies

Live

Tuesday, 17 November 2026 · 581 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

AnteoTech Flags Sales Conversion As Key Task After Revenue Falls

AnteoTech Ltd (ADO) · Health care

ADO: $0.017 +6.25% · MC: $56M

At its 2026 AGM, AnteoTech said converting its customer pipeline into sales is its top priority after FY2026 revenue fell to about $468,000 from about $969,000, partly because a Serum Institute shipment shifted into July. The company reported cash expenses down 19% and ended the year with $11 million in cash and no debt; it also highlighted battery and diagnostics progress, including Ultranode 95 testing and ongoing customer evaluations. All AGM resolutions were passed.

Source announcements: 2026-11-10 09:26 to 2026-11-10 17:03 Sydney time
Story updated 2026-11-10 17:09 Sydney time
SourcesChair's Address to ShareholdersManaging Director AGM PresentationResults of Meeting
Comments